SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹624 Cr | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr |
What is the latest Total Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹624 Cr |
| Mar2025 | ₹135 Cr |
| Mar2024 | ₹285 Cr |
| Mar2023 | ₹483 Cr |
| Mar2022 | ₹202 Cr |
How is Total Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹624 Cr | 361.75 | |
| Mar2025 | ₹135 Cr | -52.55 | |
| Mar2024 | ₹285 Cr | -40.99 | |
| Mar2023 | ₹483 Cr | 139.09 | |
| Mar2022 | ₹202 Cr | - | |
Compare Total Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹7,293.9 Cr | -1.6% | -20.7% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -1.6% |
-20.7% |
32.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses